Cargando…

Predictors of outcome after catheter ablation for atrial fibrillation: Group analysis categorized by age and type of atrial fibrillation

BACKGROUND: The outcome of catheter ablation could probably differ among patients with atrial fibrillation (AF), depending on age and AF type. We aimed to investigate the difference in predictors of outcome after catheter ablation for AF among the patient categories divided by age and AF type. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Tetsuya, Kondo, Hidekazu, Sato, Hiroki, Takahashi, Masaki, Shinohara, Tetsuji, Mitarai, Kazuki, Fukui, Akira, Hirota, Kei, Fukuda, Tomoko, Kodama, Nozomi, Miyoshi, Miho, Ogawa, Naoko, Wada, Masato, Yamasaki, Hirochika, Iwanaga, Kenzo, Uno, Akihiro, Tawara, Katsunori, Yonezu, Keisuke, Akioka, Hidefumi, Teshima, Yasushi, Yufu, Kunio, Nakagawa, Mikiko, Takahashi, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023880/
https://www.ncbi.nlm.nih.gov/pubmed/36527236
http://dx.doi.org/10.1111/anec.13020
Descripción
Sumario:BACKGROUND: The outcome of catheter ablation could probably differ among patients with atrial fibrillation (AF), depending on age and AF type. We aimed to investigate the difference in predictors of outcome after catheter ablation for AF among the patient categories divided by age and AF type. METHODS AND RESULTS: A total of 396 patients with AF (mean age 65.69 ± 11.05 years, 111 women [28.0%]) who underwent catheter ablation from January 2018 to December 2019 were retrospectively analyzed. We divided the patients into four categories: patients with paroxysmal AF (PAF) or persistent AF (PeAF) who were 75 years or younger (≤75 years) or older than 75 years (>75 years). Kaplan–Meier survival analysis demonstrated that patients with PAF aged ≤75 years had the lowest AF recurrence among the four groups (log‐rank test, p = .0103). In the patients with PAF aged ≤75 years (N = 186, 46.7%), significant factors associated with recurrence were female sex (p = .008) and diabetes (p = .042). In the patients with PeAF aged ≤75 years (N = 142, 35.9%), the only significant factor associated with no recurrence was medication with a renin‐angiotensin system inhibitor (p = .044). In the patients with PAF aged >75 years (N = 53, 14.4%), diabetes was significantly associated with AF recurrence (p = .021). No significant parameters were found in the patients with PeAF aged >75 years (N = 15, 4.1%). CONCLUSIONS: Our findings indicate that the risk factors for AF recurrence after catheter ablation differed by age and AF type.